Back
Royal Gold, Inc. Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
79
RGLD
Royal Gold, Inc.
Last Price:
$243.79
Seasonality Move:
11.85%
Buy
75
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$90.03
Seasonality Move:
-24.59%
Buy
79
Royal Gold, Inc. (RGLD)
is a Buy
Is Royal Gold, Inc. a Buy, Sell or Hold?
-
The current Royal Gold, Inc. [RGLD] share price is $242.72. The Score for RGLD is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
-
RGLD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $95.99. The Score for DRUG is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RGLD Stock Price Chart
What is Royal Gold, Inc.'s stock price today?
-
The Royal Gold, Inc. share price today is $242.72Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $95.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.26 | Buy |
| Relative Strength Index (14 RSI): | 72.3 | Buy |
| Chaikin Money Flow: | 777790 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (207.04 - 233.18) | Buy |
| Bollinger Bands (100): | (177.36 - 213.26) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.7 | Buy |
| Relative Strength Index (14 RSI): | 65.61 | Buy |
| Chaikin Money Flow: | 292843 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.33 - 88.51) | Buy |
| Bollinger Bands (100): | (45.68 - 74.86) | Buy |
RGLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 230.44 | Buy |
| 20-day SMA: | 224.95 | Buy |
| 50-day SMA: | 202.19 | Buy |
| 200-day SMA: | 183.21 | Buy |
| 8-day EMA: | 232.74 | Buy |
| 20-day EMA: | 224.23 | Buy |
| 50-day EMA: | 209.99 | Buy |
| 200-day EMA: | 184.38 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.5 | Buy |
| 20-day SMA: | 83.91 | Buy |
| 50-day SMA: | 69.69 | Buy |
| 200-day SMA: | 45.45 | Buy |
| 8-day EMA: | 85.95 | Buy |
| 20-day EMA: | 81.76 | Buy |
| 50-day EMA: | 72.81 | Buy |
| 200-day EMA: | 51.04 | Buy |
Royal Gold, Inc. Earnings Growth & RGLD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and an increase next year of $0.95 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.27 per share, and a decrease next year of $1.59 per share.
Royal Gold, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||